Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 28 | 2025 | 905 | 4.220 |
Why?
|
| Healthy Lifestyle | 10 | 2024 | 36 | 3.450 |
Why?
|
| Cardiovascular Diseases | 16 | 2025 | 235 | 3.430 |
Why?
|
| Alzheimer Disease | 13 | 2025 | 1774 | 2.810 |
Why?
|
| Life Expectancy | 9 | 2022 | 26 | 2.410 |
Why?
|
| Obesity | 10 | 2020 | 263 | 2.330 |
Why?
|
| Diet, Mediterranean | 10 | 2024 | 90 | 2.210 |
Why?
|
| Aged | 62 | 2025 | 7669 | 1.900 |
Why?
|
| Body Mass Index | 13 | 2024 | 400 | 1.780 |
Why?
|
| Prospective Studies | 31 | 2025 | 1528 | 1.740 |
Why?
|
| Exercise | 13 | 2022 | 305 | 1.670 |
Why?
|
| Female | 66 | 2025 | 12677 | 1.670 |
Why?
|
| Risk Factors | 31 | 2025 | 1942 | 1.660 |
Why?
|
| Humans | 91 | 2025 | 22848 | 1.590 |
Why?
|
| Male | 58 | 2025 | 12453 | 1.580 |
Why?
|
| Apolipoprotein E4 | 8 | 2025 | 222 | 1.530 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 135 | 1.370 |
Why?
|
| Cognition | 15 | 2024 | 1104 | 1.360 |
Why?
|
| Netherlands | 18 | 2024 | 24 | 1.330 |
Why?
|
| Independent Living | 6 | 2025 | 265 | 1.160 |
Why?
|
| Aging | 11 | 2025 | 1290 | 1.150 |
Why?
|
| Cohort Studies | 21 | 2025 | 1621 | 1.130 |
Why?
|
| Pediatric Obesity | 2 | 2018 | 40 | 1.110 |
Why?
|
| Mothers | 2 | 2018 | 143 | 1.030 |
Why?
|
| Stroke | 5 | 2023 | 207 | 1.020 |
Why?
|
| Neurodegenerative Diseases | 6 | 2025 | 96 | 0.940 |
Why?
|
| Chicago | 16 | 2025 | 808 | 0.900 |
Why?
|
| Aged, 80 and over | 23 | 2025 | 4055 | 0.870 |
Why?
|
| Waist Circumference | 4 | 2016 | 26 | 0.870 |
Why?
|
| Middle Aged | 30 | 2024 | 7555 | 0.850 |
Why?
|
| Vitamin D | 2 | 2022 | 33 | 0.810 |
Why?
|
| Dementia | 6 | 2024 | 484 | 0.790 |
Why?
|
| DNA Methylation | 6 | 2021 | 138 | 0.780 |
Why?
|
| Risk Assessment | 7 | 2024 | 485 | 0.770 |
Why?
|
| Overweight | 5 | 2021 | 58 | 0.730 |
Why?
|
| Longitudinal Studies | 10 | 2025 | 1122 | 0.720 |
Why?
|
| Blood Pressure | 3 | 2024 | 160 | 0.720 |
Why?
|
| Menopause | 5 | 2024 | 71 | 0.710 |
Why?
|
| Epigenomics | 4 | 2021 | 17 | 0.700 |
Why?
|
| Brain | 6 | 2024 | 1324 | 0.680 |
Why?
|
| United States | 9 | 2024 | 1726 | 0.670 |
Why?
|
| Dietary Approaches To Stop Hypertension | 4 | 2024 | 32 | 0.640 |
Why?
|
| Incidence | 9 | 2025 | 649 | 0.610 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 1 | 0.600 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 45 | 0.600 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 16 | 0.600 |
Why?
|
| Mortality | 2 | 2016 | 75 | 0.590 |
Why?
|
| Preconception Care | 1 | 2018 | 1 | 0.580 |
Why?
|
| Patient Compliance | 1 | 2018 | 117 | 0.550 |
Why?
|
| Biomarkers | 8 | 2025 | 453 | 0.540 |
Why?
|
| Lipids | 3 | 2025 | 46 | 0.540 |
Why?
|
| Life Style | 4 | 2022 | 127 | 0.530 |
Why?
|
| Proportional Hazards Models | 8 | 2024 | 270 | 0.530 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 16 | 0.520 |
Why?
|
| Obesity, Metabolically Benign | 1 | 2016 | 1 | 0.510 |
Why?
|
| Body Composition | 1 | 2016 | 52 | 0.490 |
Why?
|
| tau Proteins | 3 | 2025 | 197 | 0.480 |
Why?
|
| Anthropometry | 1 | 2015 | 28 | 0.480 |
Why?
|
| Alleles | 4 | 2024 | 173 | 0.470 |
Why?
|
| Somatotypes | 1 | 2014 | 2 | 0.470 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 1494 | 0.430 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 233 | 0.390 |
Why?
|
| Postmenopause | 3 | 2018 | 47 | 0.380 |
Why?
|
| Carotid Intima-Media Thickness | 3 | 2022 | 16 | 0.380 |
Why?
|
| Adult | 11 | 2024 | 6584 | 0.380 |
Why?
|
| Risk Reduction Behavior | 4 | 2020 | 31 | 0.380 |
Why?
|
| Environmental Exposure | 2 | 2024 | 14 | 0.370 |
Why?
|
| Diet | 5 | 2024 | 199 | 0.370 |
Why?
|
| Air Pollution | 2 | 2024 | 14 | 0.360 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 65 | 0.360 |
Why?
|
| CpG Islands | 4 | 2021 | 46 | 0.360 |
Why?
|
| Atherosclerosis | 3 | 2022 | 42 | 0.360 |
Why?
|
| White Matter | 2 | 2022 | 116 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 311 | 0.330 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 977 | 0.320 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 71 | 0.300 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 75 | 0.300 |
Why?
|
| Pandemics | 2 | 2020 | 201 | 0.300 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 217 | 0.290 |
Why?
|
| Population Surveillance | 2 | 2021 | 103 | 0.290 |
Why?
|
| Intermediate Filaments | 3 | 2023 | 16 | 0.290 |
Why?
|
| Coronary Disease | 2 | 2018 | 43 | 0.290 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 32 | 0.290 |
Why?
|
| Body Size | 2 | 2019 | 11 | 0.280 |
Why?
|
| Adolescent | 4 | 2024 | 1775 | 0.280 |
Why?
|
| Dietary Supplements | 3 | 2022 | 54 | 0.280 |
Why?
|
| Child | 3 | 2024 | 990 | 0.270 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 32 | 0.270 |
Why?
|
| Estrogen Receptor beta | 2 | 2016 | 5 | 0.250 |
Why?
|
| Prevalence | 3 | 2023 | 377 | 0.250 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 85 | 0.250 |
Why?
|
| Sex Factors | 5 | 2020 | 381 | 0.240 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 269 | 0.240 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 71 | 0.240 |
Why?
|
| Waist-Hip Ratio | 2 | 2015 | 12 | 0.240 |
Why?
|
| Coffee | 1 | 2024 | 3 | 0.230 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.230 |
Why?
|
| Beverages | 1 | 2024 | 11 | 0.230 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.230 |
Why?
|
| Particulate Matter | 1 | 2024 | 18 | 0.230 |
Why?
|
| Social Isolation | 1 | 2025 | 29 | 0.230 |
Why?
|
| Loneliness | 1 | 2025 | 56 | 0.220 |
Why?
|
| Weight Gain | 3 | 2024 | 55 | 0.220 |
Why?
|
| Dietary Fats | 1 | 2024 | 37 | 0.220 |
Why?
|
| Whole Grains | 1 | 2023 | 7 | 0.210 |
Why?
|
| Memory Disorders | 1 | 2024 | 128 | 0.210 |
Why?
|
| Florida | 1 | 2023 | 15 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 233 | 0.210 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2022 | 2 | 0.200 |
Why?
|
| Vitamin E | 1 | 2023 | 42 | 0.200 |
Why?
|
| Time Factors | 7 | 2021 | 1220 | 0.200 |
Why?
|
| Flavonols | 1 | 2022 | 11 | 0.200 |
Why?
|
| Betacoronavirus | 2 | 2020 | 61 | 0.200 |
Why?
|
| Comorbidity | 3 | 2022 | 354 | 0.200 |
Why?
|
| Vitamins | 1 | 2022 | 18 | 0.200 |
Why?
|
| Smoking | 3 | 2020 | 163 | 0.190 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 22 | 0.190 |
Why?
|
| Survivors | 1 | 2022 | 49 | 0.190 |
Why?
|
| Lutein | 1 | 2021 | 4 | 0.190 |
Why?
|
| Zeaxanthins | 1 | 2021 | 4 | 0.190 |
Why?
|
| Carotenoids | 1 | 2021 | 17 | 0.180 |
Why?
|
| Health Status | 2 | 2019 | 173 | 0.180 |
Why?
|
| Lipoproteins, HDL | 1 | 2021 | 19 | 0.180 |
Why?
|
| Diet Surveys | 1 | 2021 | 24 | 0.180 |
Why?
|
| Leukocytes | 1 | 2021 | 29 | 0.180 |
Why?
|
| Nurses | 2 | 2018 | 37 | 0.180 |
Why?
|
| Body Weight | 2 | 2018 | 116 | 0.180 |
Why?
|
| Diet, Western | 1 | 2021 | 11 | 0.180 |
Why?
|
| Weight Loss | 2 | 2020 | 107 | 0.170 |
Why?
|
| Amyloid | 1 | 2021 | 47 | 0.170 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 982 | 0.170 |
Why?
|
| Eczema | 1 | 2020 | 3 | 0.170 |
Why?
|
| Lipase | 1 | 2020 | 3 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2021 | 144 | 0.170 |
Why?
|
| Phenotype | 2 | 2018 | 254 | 0.170 |
Why?
|
| Dyslipidemias | 2 | 2019 | 12 | 0.170 |
Why?
|
| Neoplasms | 2 | 2020 | 205 | 0.170 |
Why?
|
| Rhinitis, Allergic | 1 | 2020 | 15 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 101 | 0.170 |
Why?
|
| Pancreas | 1 | 2020 | 28 | 0.170 |
Why?
|
| Food Hypersensitivity | 1 | 2020 | 39 | 0.170 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 177 | 0.170 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2018 | 13 | 0.170 |
Why?
|
| Inbreeding Depression | 1 | 2019 | 3 | 0.160 |
Why?
|
| Consanguinity | 1 | 2019 | 3 | 0.160 |
Why?
|
| Autopsy | 1 | 2021 | 275 | 0.160 |
Why?
|
| Fertility | 1 | 2019 | 11 | 0.160 |
Why?
|
| Cholesterol, HDL | 2 | 2016 | 22 | 0.160 |
Why?
|
| Risk-Taking | 1 | 2019 | 24 | 0.160 |
Why?
|
| Asthma | 1 | 2020 | 83 | 0.160 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 20 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 22 | 0.160 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 249 | 0.150 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 4 | 0.150 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 377 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2017 | 40 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2018 | 38 | 0.150 |
Why?
|
| Androgens | 1 | 2018 | 7 | 0.150 |
Why?
|
| Child Behavior | 1 | 2018 | 24 | 0.150 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 23 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 56 | 0.150 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 1 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2018 | 8 | 0.150 |
Why?
|
| Testosterone | 1 | 2018 | 20 | 0.150 |
Why?
|
| Basal Metabolism | 1 | 2018 | 8 | 0.140 |
Why?
|
| Diet, Reducing | 1 | 2018 | 12 | 0.140 |
Why?
|
| Thiocyanates | 1 | 2017 | 4 | 0.140 |
Why?
|
| Perchlorates | 1 | 2017 | 5 | 0.140 |
Why?
|
| Hospitalization | 1 | 2020 | 272 | 0.140 |
Why?
|
| Nitrates | 1 | 2017 | 9 | 0.140 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 12 | 0.140 |
Why?
|
| Vascular Calcification | 1 | 2017 | 9 | 0.140 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 1 | 0.140 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 1 | 0.140 |
Why?
|
| Health Personnel | 1 | 2018 | 93 | 0.140 |
Why?
|
| Aspartate Aminotransferases | 1 | 2017 | 12 | 0.140 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 13 | 0.140 |
Why?
|
| Protective Factors | 4 | 2018 | 22 | 0.140 |
Why?
|
| Fatty Liver | 1 | 2017 | 26 | 0.140 |
Why?
|
| Pregnancy | 1 | 2018 | 303 | 0.130 |
Why?
|
| Transportation | 1 | 2016 | 3 | 0.130 |
Why?
|
| Inhalation Exposure | 1 | 2016 | 3 | 0.130 |
Why?
|
| Histones | 1 | 2016 | 25 | 0.130 |
Why?
|
| Actigraphy | 1 | 2016 | 73 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2022 | 807 | 0.130 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 3 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2016 | 26 | 0.130 |
Why?
|
| Child, Preschool | 1 | 2018 | 489 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 10 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 713 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 4 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 43 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 5 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 500 | 0.130 |
Why?
|
| Waist-Height Ratio | 1 | 2015 | 4 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2016 | 65 | 0.120 |
Why?
|
| Health Behavior | 1 | 2016 | 123 | 0.120 |
Why?
|
| Cause of Death | 3 | 2022 | 50 | 0.120 |
Why?
|
| Sweating | 1 | 2014 | 2 | 0.120 |
Why?
|
| Hot Flashes | 1 | 2014 | 9 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 227 | 0.110 |
Why?
|
| Perimenopause | 1 | 2014 | 10 | 0.110 |
Why?
|
| Copper | 2 | 2024 | 18 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 401 | 0.110 |
Why?
|
| Prognosis | 1 | 2015 | 630 | 0.100 |
Why?
|
| Risk | 3 | 2018 | 178 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 274 | 0.100 |
Why?
|
| Age Factors | 3 | 2022 | 657 | 0.100 |
Why?
|
| Triglycerides | 2 | 2025 | 54 | 0.090 |
Why?
|
| Cholesterol | 2 | 2025 | 59 | 0.090 |
Why?
|
| Genotype | 2 | 2024 | 301 | 0.090 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 32 | 0.080 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2021 | 2 | 0.080 |
Why?
|
| Educational Status | 2 | 2021 | 253 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 22 | 0.070 |
Why?
|
| Walking | 2 | 2021 | 207 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 236 | 0.060 |
Why?
|
| Switzerland | 1 | 2024 | 7 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Tea | 1 | 2024 | 5 | 0.060 |
Why?
|
| Heterozygote | 1 | 2025 | 71 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 23 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2024 | 34 | 0.060 |
Why?
|
| Food Handling | 1 | 2024 | 2 | 0.060 |
Why?
|
| Fast Foods | 1 | 2024 | 5 | 0.060 |
Why?
|
| Energy Intake | 1 | 2024 | 78 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2024 | 80 | 0.050 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2023 | 9 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2023 | 15 | 0.050 |
Why?
|
| Hypertension | 1 | 2024 | 156 | 0.050 |
Why?
|
| Tocopherols | 1 | 2023 | 7 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 11 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 11 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 12 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 7 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2022 | 20 | 0.050 |
Why?
|
| Brain Infarction | 1 | 2023 | 54 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 53 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 74 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 7 | 0.050 |
Why?
|
| United Kingdom | 1 | 2022 | 42 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2022 | 48 | 0.050 |
Why?
|
| Vegetables | 1 | 2021 | 25 | 0.050 |
Why?
|
| Gene Expression | 1 | 2022 | 166 | 0.050 |
Why?
|
| Accelerometry | 1 | 2021 | 69 | 0.050 |
Why?
|
| Executive Function | 1 | 2021 | 93 | 0.040 |
Why?
|
| Music Therapy | 1 | 2020 | 4 | 0.040 |
Why?
|
| Meditation | 1 | 2020 | 18 | 0.040 |
Why?
|
| Intubation | 1 | 2020 | 6 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 16 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 70 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 17 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 23 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 47 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 82 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 24 | 0.040 |
Why?
|
| Animals | 2 | 2016 | 3025 | 0.040 |
Why?
|
| ADAMTS9 Protein | 1 | 2018 | 1 | 0.040 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 2 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lod Score | 1 | 2018 | 9 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 79 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 1 | 0.040 |
Why?
|
| Androstenedione | 1 | 2018 | 5 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 89 | 0.040 |
Why?
|
| Rest | 1 | 2018 | 25 | 0.040 |
Why?
|
| Symporters | 1 | 2017 | 7 | 0.040 |
Why?
|
| Life Tables | 1 | 2017 | 5 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 177 | 0.030 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 1 | 0.030 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2017 | 1 | 0.030 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 1 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 3 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2017 | 7 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 685 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 35 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 104 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 46 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 1 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Histone Code | 1 | 2016 | 1 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 300 | 0.030 |
Why?
|
| Bias | 1 | 2016 | 24 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 320 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 25 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 218 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 37 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 42 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 125 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 241 | 0.030 |
Why?
|
| Cardiology | 1 | 2016 | 23 | 0.030 |
Why?
|
| Health | 1 | 2016 | 9 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 54 | 0.030 |
Why?
|
| Gardening | 1 | 2016 | 1 | 0.030 |
Why?
|
| Bicycling | 1 | 2016 | 3 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 82 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 126 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 122 | 0.030 |
Why?
|
| Arteries | 1 | 2016 | 12 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2016 | 55 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 61 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 47 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2016 | 121 | 0.030 |
Why?
|
| Sports | 1 | 2016 | 59 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 107 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 158 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 333 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 226 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2014 | 2 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 354 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 588 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 2960 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 556 | 0.020 |
Why?
|